Mariner, LLC Ab Cellera Biologics Inc. Transaction History
Mariner, LLC
- $75.9 Billion
- Q3 2025
A detailed history of Mariner, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Mariner, LLC holds 15,792 shares of ABCL stock, worth $58,272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,792Holding current value
$58,272% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ABCL
# of Institutions
169Shares Held
109MCall Options Held
1.26MPut Options Held
788K-
Baker Bros. Advisors LP New York, NY27.5MShares$102 Million1.13% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$49.3 Million0.01% of portfolio
-
Baillie Gifford & CO10.4MShares$38.5 Million0.04% of portfolio
-
Two Sigma Investments, LP New York, NY5.18MShares$19.1 Million0.04% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny4.8MShares$17.7 Million0.05% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.05B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...